Skip to main content
logo
Cynata Therapeutics Limited (ASX:CYP)
Australia flag Australia · Delayed Price · Currency is AUD
0.3250
+0.0050 (1.56%)
Jan 30, 2026, 12:55 PM AEST

Cynata Therapeutics Revenue

In the fiscal year ending June 30, 2025, Cynata Therapeutics had annual revenue of 1.89M AUD, down -18.59%. Cynata Therapeutics had revenue of -84.99K in the half year ending June 30, 2025.

Revenue
1.89M
Revenue Growth
-18.59%
P/S Ratio
41.04
Revenue / Employee
942.57K
Employees
2
Market Cap
77.36M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20251.89M-430.50K-18.59%
Jun 30, 20242.32M661.33K39.98%
Jun 30, 20231.65M-6.12M-78.71%
Jun 30, 20227.77M6.22M402.60%
Jun 30, 20211.55M-5.47M-77.95%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
EZZ Life Science Holdings66.87M
Radiopharm Theranostics12.51M
Alterity Therapeutics5.44M
Amplia Therapeutics5.01M
Imugene4.40M
Prescient Therapeutics4.36M
Arovella Therapeutics3.44M
Entropy Neurodynamics1.58M
Revenue Rankings

Cynata Therapeutics News

More News